V Herbert. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Ascorbic Acid/administration & dosageAscorbic Acid/adverse effectsChelating Agents/therapeutic useDeferoxamine/therapeutic useDietary Supplements/adverse effectsDrug Therapy, CombinationHemochromatosis/complicationsHemochromatosis/drug therapyHumans
Substances: See more » Chelating AgentsDeferoxamineAscorbic Acid
Year: 1999 PMID: 10498572 DOI: 10.7326/0003-4819-131-6-199909210-00021
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391